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Abstract L-citrulline (Cit) is a co-product of NO synthesis
and a direct L-arginine (Arg) precursor for de novo NO
synthesis. Acute liver failure (ALF) is associated with in-
creased nitric oxide (NO) and cyclic GMP (cGMP) synthesis
in the brain, indirectly implicating a role for active transport of
Cit. In the present studywe characterized [3H]Cit uptake to the
cortical brain slices obtained from control rats and rats with
thioacetamide (TAA)-induced ALF (“TAA slices”). In both
control and TAA slices the uptake was partially Na+-depen-
dent and markedly inhibited by substrates of systems L and N,
including L-glutamine (Gln), which accumulates in excess in
brain during ALF. Cit uptake was not affected by Arg, the y+/
y+L transport system substrate, nor by amino acids taken up
by systems A, xc
−or XAG. The Vmax of the uptake in TAA
slices was ~60 % higher than in control sl ices.
Chromatographic (HPLC) analysis revealed a ~30 % increase
of Cit concentration in the cerebral cortical homogenates of
TAA rats. The activity of argininosuccinate synthase (ASS)
and argininosuccinate lyase (ASL), the two enzymes of Cit-
NO cycle catalyzing synthesis of Arg, showed an increase in
TAA rats, consistent with increased ASS and ASL protein
expression, by ~30 and ~20 %, respectively. The increased
Cit-NO cycle activity was paralleled by increased expression
of mRNA coding for inducible nitric oxide synthase (iNOS).
Taken together, the results suggest a role for Cit in the activa-
tion of cerebral NO synthesis during ALF.
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Introduction
Hepatic encephalopathy (HE), a consequence of acute or
chronic liver failure (ALF or CLF), is a complex neuropsy-
chiatric disorder that results from impaired clearance from
blood of ammonia and other toxins, and is compounded by
peripheral or local inflammatory processes (Prakash and
Mullen 2010). The cellular and molecular mechanisms under-
lying HE are complex, but are as a rule associated with
interference of ammonia with various aspects of brain metab-
olism, leading to imbalance of neural transmission (Albrecht
and Jones 1999; Felipo and Butterworth 2002). At the molec-
ular level the activation of ionotropic (mainly NMDA) gluta-
mate receptors leads to increased intracellular free calcium
which, after binding to calmodulin, activates nitric oxide
synthase (NOS), leading to increased production of nitric
oxide (NO) (Garthwaite et al. 1988). In ALF, ammonia-
induced increase of NO and subsequently extracellular
cGMP is a good indicator of the over-stimulation of NMDA
receptors in rat brain, a process that contributes to increased
reactive oxygen and nitrogen species (ROS/RNS) production
(Kosenko et al. 2003; Hermenegildo et al. 2000; Hilgier et al.
2004). Increased NO synthesis under HE conditions in the
brain, requires L-arginine (Arg) as a substrate for NOS, which
generates NO and L-citrulline (Cit). Arg is a semi-essential
amino acid in CNS and its availability depends both upon its
uptake from the circulation (Fotiadis et al., 2013) and the
recycling of Cit to Arg in Cit-NO cycle (Zhang et al. 1999,
see also Scheme 1). Cit generated as a by-product of NO
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synthesis can be recycled to Arg in reactions subsequently
catalyzed by argininosuccinate synthetase (ASS; EC 6.3.4.5)
and argininosuccinate lyase (ASL; EC 4.3.2.1) via the Cit-NO
cycle (Scheme 1). The activity of ASS and ASL was found
increased in cerebral cortex of hyperammonemic rats (Swamy
et al. 2005). Also, increased Arg uptake has been repeatedly
demonstrated in ammonia-exposed synaptosomes
(Westergaard et al. 1993; Rao and Butterworth 1996; Rao
et al. 1997; Rao 2002) and astrocytes (Hazell and Norenberg
1998). Infusion of ammonium acetate to rats increased serum
level of Arg, suggesting increased availability of Arg for NO
synthesis (Ishihara et al. 1998). However, in TAA-induced
ALF, the total blood to brain barrier transport of Arg was
decreased, as determined by the brain uptake index (BUI)
(Albrecht et al. 1996). Moreover, TAA-induced HE was as-
sociated with increased conversion of Arg to neurotransmit-
ters Glu and γ-aminobutyric acid (GABA), a process engag-
ing increased activities of arginase (AR; EC 3.5.3.1) and
ornithine aminotransferase (OAT; EC 2.6.1.13) (Albrecht
et al. 1990). On the other hand, elevated concentration of L-
glutamine (Gln) in hyperammonemic rat brain inhibits cGMP
synthesis by interaction with Arg transport into the cells
(Zielinska et al. 2011), which could counter the increase of
NO synthesis by ammonia. One other mechanism by which
Gln could affect NO synthesis in the brain is by interference
with Cit recycling to Arg, as shown by Wu and Meininger
(1993) in peripheral endothelial cells. The potential impor-
tance of Cit recycling for Arg availability and NO synthesis in
HE affected brain prompted us to analyze the as yet not
considered Cit transport as a critical step within the Cit-NO
cycle. The present study is, to the best of our knowledge, the
first which attempted to characterize in more detail Cit trans-
port in ex vivo brain tissue.
Experimental procedures
HE model
Adult male Sprague–Dawley rats (150–180 g) were reared
under standard conditions at the local animal facility. The
animals had free access to food and water. All experiments
were performed with agreement of local animal ethical com-
mittee that approved the experimental design. HE with cere-
bral metabolic changes and symptoms typical of acute HEwas
induced by 3 i.p. injections of thioacetamide (TAA) (250 mg
per kg of body weight) at 24 h hours intervals (Hilgier and
Olson 1994; Hilgier et al. 1996) and sacrificed 24 h after third
injection. Control rats were analogically injected with sodium
saline solution.
Cerebral cortical slices
Male Sprague-Dowley rats (150–180 g) were used through-
out. In essence, a previously described procedure was follow-
ed (Zielińska et al. 1999) with slight modifications. Animals
were decapitated and the brains were immediately transferred
into ice-cold Krebs-Ringer bicarbonate buffer (Krebs buffer)
of the following composition: 118 mM NaCl, 25 mM
NaHCO3, 4.7 mM KCl, 1.2 mM KH2PO4, 2.5 mM CaCl2,
1.2 mM MgSO4, 10 mM glucose, aerated with 95 % O2 and
5%CO2 at pH 7.4. After preparation the cortices were cut into
300 μm slices using a manual chopper. The slices were
transferred to borosilicate glass vials containing Krebs buffer.
Each vial received its own supply of a 95 % O2 and 5 % CO2
gas mixture. The slices were pre-incubated under these con-
ditions for 30 min in a water bath at 37.4 °C.
Uptake experiments
After pre-incubation of cerebral cortical slices the uptake was
started by adding [3H]Cit at 100 μmol/L final concentration
and the incubation was continued for 7 min. Kinetics of [3H]
Cit uptake was determined in Na+-containing medium over
varying extracellular Cit concentrations (2.5–1,000 μM).
Substrate preference analysis was measured in a competition
study where 100 μM/L [3H]Cit was used together with
unlabelled Cit in the presence of a number of 0.5–10 mM
competing unlabelled L-amino acids or MeAIB (all substrates
were from Sigma- Aldrich, USA).
The incubation was terminated by a rapid vacuum filtration
through 2.5 cm 0.45 μm Millipore filter disks (Millipore,
Scheme 1 The Cit-NO cycle in the brain. As suggested by this study, in
TAA-induced ALF, increased amounts of Cit enter the brain cells, due to
increased Cit uptake activity (as indicated by bold arrow). The increased
Cit content in the brain tissue, stimulation of ASS and ASL, and increased
iNOS expression, cooperatively enhance the Cit-NO cycle activity, pos-
itively modulating the NO tissue content
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Ireland), followed by three washes with 2 ml with Krebs
buffer maintained at 4 °C. The radioactivity on filter disks
was measured in a Wallac 1409 Liquid Scintillation Counter
(Perkin - Elmer, Finland). Correction for the remaining citrul-
line in the extracellular space was included in blank samples,
defined as zero-time incubation (<20 s) and accounted for
about~7–10 % of the total uptake. Protein determination
was performed according to Bradford’s procedure (Bradford
1976).
Argininosuccinate synthetase and argininosuccinate lyase
activity measurements
Argininosuccinate synthetase (ASS) and arginosuccinate ly-
ase (ASL) activity was measured by a modification of a
method of Swamy et al. (2005). Briefly, the cortical tissue
was weighed and homogenized in 0.05 M phosphate buffer at
pH 7.3 and 4 °C. The assay of ASS was started by the addition
of 0.2 ml of 20 % homogenate to the reaction mixture
contained Cit, aspartic acid, ATP, magnesium chloride, each
at 0.01 M concentration and 21U of arginase. The reaction
was conducted at 37 °C and stopped after 1 h by addition of
0.2 ml of 50 % trichloracetic acid. The reaction mixture was
then centrifuged and supernatant was used for colorimetric
determination of urea. The absorbance was read at 540 nm.
The react ion mixture for ASL assay contained
argininosuccinate at 6.0 mM and 10.5 U of arginase and was
started by addition of 0.2 ml of 20 % homogenate to the
reaction mixture.
L-citrulline determination in cerebral cortical homogenates
Cit was analysed using HPLC with fluorescence detection
after derivatisation in a timed reaction with o-phthalaldehyde
plus mercaptoethanol, as described earlier (Zielińska et al.
1999). Derivatised samples (50 μl of microdialysate) were
injected onto 150×4.6 mm 5 μm Hypersil ODS column,
eluted with a mobile phase of 0.075 M KH2PO4 solution
containing 10 % (v/v) methanol, pH 6.2 (solvent A), and
methanol (solvent B). The methanol gradient was 20–70 %
and the elution time 20 min.
Protein isolation and Western blot analysis
Isolated rat brain cerebral cortexes were homogenized and
centrifuged at 4ºC with Triton Lysis Buffer as described
earlier (Zielinska et al. 2011). Total protein concentration in
supernatants was determined by the Lowry method using
Modified Lowry Protein Assay Reagent (Pierce). Protein
(30 μg) was mixed with sample loading buffer, separated on
SDS-PAGE and then transferred onto nitrocellulose mem-
brane. The membranes were blocked with 5 % non-fat dry
milk in TBS-T buffer. Incubation with antibodies against ASS
(1:1,000, Sigma-Aldrich, USA) and ASL (1:1,000, Sigma-
Aldrich, USA) was done in TBS-T buffer with 5 % non-fat
dry milk at 4 °C temperature over night followed by 10 min
incubation with peroxidase-conjugated-anti-rabbit antibodies
(1:2,500, Sigma-Aldrich, USA) for detection by SuperSignal
West Pico Chemiluminescent Substrate (Pierce). The first
antibody was stripped off with 0.1 M glycine, pH 2.9, and
second incubation was performed with an antibody against
GAPDH (1 h at room temperature), (1:5,000, Sigma-Aldrich,
USA).
Real-time PCR analysis
Total RNA was isolated using TRI Reagent (Sigma-Aldrich,
USA), and then 1 μg was reverse-transcribed using the High
Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Life Technologies). Real time PCR was per-
formed in 96 well plates with the ABI 7500 apparatus
(Applied Biosystems, Life Technologies) using the MGB
Taqman probe assay. Probes for iNOS and endogenous con-
trol β-actin were purchased from Applied Biosystems (Rn
00561646-m1 and Rn 00667869-m1, respectively). Each re-
action contained 5 μl Taqman Universal PCR Mastermix in a
total volume of 10 μl, and 1 μl cDNA was added to the
reaction. The real time PCR reactions were performed at
95 °C for 10 min, followed by 40 cycles of 30 s at 95 °C
and 1 min at 60 °C. The results of the analysis were calculated
in relation to the β-actin product, and results were calculated
according to, and expressed by an equation (2-ΔΔCt) that gives
the amount of target, normalized to an endogenous reference
and relative to a calibrator. CT is the threshold cycle for target
amplification (Livak and Schmittgen 2001).
Statistical analysis
Statistical analysis of the data was performed using one-way
analysis of variance followed by the Dunnet’s comparison test
or the two-tailed Student’s test.
Results
Kinetics of [3H]Cit uptake to the rat cerebral cortical slices
was analyzed using Michaelis–Menten nonlinear analysis
(Fig. 1a) and linearized transformation Eadie–Hofstee
(Fig. 1b). The analyzes revealed a simple, one component of
the uptake, where VMAX of increased from 289±59 to 471±
84 pmol mg−1 protein x min−1, whereas KM, though slightly
increased (from 11±4 to 25±6 mM) in slices obtained from
TAA-induces ALF rats (TAA) (Fig. 1a). Transport of [3H]Cit
was partially dependent on extracellular Na+, (Table 1) and
significantly inhibited by a 10-fold excess of unlabelled Cit,
L-histidine (His; substrate for system L), L-glutamine (Gln;
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substrate for systems L and N) or different concentrations of
L-phenylalanine (Phe; substrate for system L) and 6-diazo-5-
oxo-l-norleucine (DON; model substrate for system N). In
contrast, 2-methylaminoisobutyric acid (MeAIB) and L-
glutamate (Glu) (substrates for systems A and xc -/XAG),
respectively, were ineffective inhibitors, as well as L-
arginine (Arg), a substrate for y+ system (Table 1). Detailed
analysis of the inhibition of [3H]Cit transport in control and
TAA slices by DON revealed inhibition in a concentration-
dependent manner, reducing [3H]Cit uptake by ~54, ~39,
~29 % and ~70, ~55 and ~50 %, respectively at 5; 2.5; and
1 mM concentration (Fig. 2a). In contrast, the inhibition
caused by 3 mM Phe was not further enhanced by increasing
extracellular Phe to 15 mM (Fig. 2b).
Chromatographic analysis of cerebral homogenates obtain-
ed from control and TAA rats revealed an increase in total
tissue concentration of Cit from 1.3±0.2 to 1.7±0.1 μM/g of
tissue (Table 2). In TAA rats total tissue concentration of Arg
increased from 10.6±0.6 to 7.2±0.2 (Table 2). The mRNA
expression of iNOSwas increased in TAA cortex by ~20% of
control, respectively (Fig. 3). TAA increased the activity of
ASS (0.5-fold) and ASL (0.9-fold) in cerebral cortical homog-
enates (Fig. 4a). Western blot analysis showed increased ex-
pression of ASS (~0.3-fold) and ASL (~0.2-fold) in TAA rats
(Fig. 4b).
Discussion
In the brain, astrocytes are the main site of ammonia detoxi-
fication, through the amidation of glutamate (Glu) forming
Gln (Cooper and Plum 1987), in the reaction catalyzed by
glutamine synthetase (GS) (Martinez-Hernandez et al. 1977).
Accumulation of Gln in the brain in HE patients or animal
models of ALF is one of the main factors that contribute to
ammonia-induced neurotoxicity (Albrecht and Norenberg
2006). HE impairs the glutamate/NO/cGMP pathway, which
includes interference with the synthesis of NO (Hermenegildo
et al. 1998; 2000; Hilgier et al. 2004; for a review see Felipo
2006). Previously we showed that the impairment of the NO-
cGMP pathway may also result from the interference of Gln
with Arg availability for NO synthesis. However, as was
suggested by Wu and Meininger (1993) in the study on
peripheral endothelial cells, Gln could also affect NO synthe-
sis in the brain by interfering with recycling of the Arg
precursor Cit. The capacity of the enzymes involved in Arg
regeneration from Cit may represent a rate limiting mecha-
nism in brain cells for maintaining substrate supply for NO
synthesis. In relevance to the above consideration, activation
of the Cit-NO biosynthetic pathway related to the markedly
enhanced ASS, the rate-limiting enzyme in the pathway, was
observed in alcoholic liver (Leung et al. 2012). In the present
study, ALF caused a parallel increase of ASS activity and
iNOS expression. To this point, the present study supports the
few previous observations made in other experimental
Fig. 1 a–bKinetics of L-citrulline transport measured in cerebral cortical
slices derived from control and TAA rats and analyzed in three different
modes. Results are mean ± SD (n=4–5)
Table 1 The effects of extracellular sodium and system-selective amino-
acid substrates on L-citrulline uptake in cerebral cortical slices from
control and TAA rats
Inhibitor System selectivity L-citrulline transport
(% control)
Control TAA
Na+ L,N,y+, xc,−XAG 103±19 153±18*
Na+- free A, N 72±20 89±26**
L-arginine (10 mM) y+ 71±29 101±23
L-citrulline (10 mM) ? 58±14* 82±26**
BCH (10 mM) L 48±14* 62±26**
L-glutamine (10 mM) L,N 60±14* 71±23**
L-histidine (10 mM) N 46±15* 65±21**
DON (5 mM) N 47±16* 75±22**
MeAIB (10 mM) A 98±14 102±26
L-glutamate xc−or XAG 90±17 116±20
Transport of L-citrulline (0.1 mM) was measured over 7 min in the
absence or presence of Na+ ions and an excess of system-selective
amino-acid substrates. Data are expressed as a percentage of the influx
rate in control slices (100 %=19.2 pmol mg protein-1 min-1). Values are
mean±SD of 4–6 experiments with three replicates in each experiment.
*p<0.05 vs. Control and **p<0.05 vs. to TAA
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settings. Braissant et al. (1999) showed that expression of ASS
and ASL genes is selectively induced in astrocytes treated
with 5 mM NH4Cl, also suggesting increased recycling of Cit
to Arg. Moreover, the study Sharma et al. (2012) on
devascularized porcine model of ALF provided indirect evi-
dence for increased de novo synthesis of Arg via Cit-NO
cycle.
One as yet unattended step in this cycle of potential
rate-limiting impact was the uptake of the Arg precursor
Cit. In this study therefore we characterized Cit uptake to
the cerebrocortical slices obtained from control rats and
rats with TAA-induced ALF, considering this as a poten-
tial additive factor in Arg supply for NO synthesis. The
study by Albrecht et al. (1996) has analyzed a different
stage of the TAA model: the animals were in the recovery
period after the TAA insult (7 or 28 days). By contrast
rats with TAA induced HE in the model here described
(Albrecht et al. 1990) presented increased conversion of
Arg to downstream metabolites. There is limited informa-
tion on Cit transport in brain preparations or cells, and the
properties of transporters involved in Cit uptake in pe-
ripheral tissues show considerable variations. For exam-
ple, Cit uptake is predominantly Na+ -dependent in rat
small interstitium (Vadgama and Evered 1992), but is
primarily Na+ -independent and mediated by system L,
and only partly by system N in rat aortic smooth muscle
cells (Wileman et al. 2003). In turn, in pulmonary arterial
endothelial cells, exposure to hypoxia evokes system A-
mediated Cit uptake (Fike et al. 2012). In rat kidney
slices, Cit uptake was largely mediated by the Na+-inde-
pendent organic anion transporter, OAT1 (Nakakariya
et al. 2009). The characteristics of Cit uptake to brain
slices showed many features in common with those de-
scribed in aortic smooth muscle cells or rat small intersti-
tium, largely matching transport systems N and L.
Rat cerebral cortical [3H]Cit uptake was increased by TAA-
induced ALF rat cortex. The increase of Vmax of the uptake
could be partially due to increased activity of the transporter
and/or elevated total Cit concentration in the tissue (Table 2);
the relative quantitative contribution of either of the two
variables remains to be analyzed in more detail. Increased
Cit uptake could be ascribed to two transporting systems:
N and L. The involvement of the two systems is consistent
with a previous report that Cit uptake in a variety of neural cell
cultures is Na+-independent (Schmidlin et al. 2000). The
involvement of the two systems indicates that in the setting
of HE, the uptake would show increased sensitivity to, and
thus a preponderance to be regulated by, a number of amino
acids which are substrates of this system. Of note in this
context, system L substrates Gln and Try show increased brain
concentration in this model (Hilgier et al. 1992); their specific
modulatory role in the Cit-NO cycle remains to be envisaged.
While inhibition of Cit uptake by MeAIB and glutamate in
TAA cortical slices could suggest the activation of other
transport systems (A, xc
−or XAG), decreased expression of
Fig. 2 Specificity of L-citrulline transport in cerebral cortical slices from
control and TAA rat brain. Inhibition of L-citrulline transport was mea-
sured in slices incubated with Na+ containing Krebs buffer with increas-
ing concentrations (0.5–5 mM) of DON (A) or L-phenylalanine (B). (C)
Kinetic analysis of Cit uptake in the presence of 5 mM Gln. Transport of
L-citrulline (0.1 mM) was measured over 7 min, and expressed as a
percentage of the transport rate determined in the absence of an inhibitor
amino acid. Values are mean ± SD (n=5–6)
Table 2 Total concentration of L-citrulline and L-arginine in cortical
slices from control and TAA rats





Results are mean ± SD; (n=6) *p<0.05 vs. “Control”
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mRNA expression of two members of system A (SAT1,
SAT2) (unpublished observations) tends to exclude this pos-
sibility. The involvement of systems: A, xc
- and XAG in Cit
transport deserves further investigation.
In conclusion, increased Cit uptake plus elevation of
other parameters of the Cit-NO cycle unambiguously
point to its stimulatory effect on NO synthesis in the
setting of ALF, as illustrated in Scheme 1. To summarize
briefly, Cit concentration in brain homogenates from TAA
rat was elevated (Table 2), and so were the activities and
expression of the two pertinent enzymes: ASS and ASL
(Fig. 4a, b). One other factor with a potential to speed up
the operation of the cycle is increased NOS activity. NO
synthesis was repeatedly found elevated in different HE
models (Schliess et al. 2002; Hilgier et al. 2004; 2009;
Sharma et al. 2012), mostly due to increased iNOS, as
shown in rats with chronic liver failure due to portacaval
shunt (Rodrigo et al. 2007). In agreement with the previ-
ously reported data, here we document increased expres-
sion of iNOS mRNA in the TAA model of ALF. It
remains to be confirmed whether the increase of mRNA
is translated to increased iNOS protein level and NOS
activity, as suggested by data from other groups
(Rodrigo et al. 2007; Balasubramaniyan et al. 2012).
Clearly, elucidation the role of NO synthesis in the pres-
ent model will require an analysis of other NOS isoforms
at the level of transcription, translation and enzyme activ-
ity. On the other hand, it must be kept in mind that Cit has
only a limited ability to sustain maximal rates of NO
Fig. 3 The expression of iNOS mRNA in the cerebral cortex of control
and TAA rats. Results are mean ± SD; (n=5) *p<0.05 vs. “Control”
Fig. 4 The activity (a) and
protein expression (b) of
arginosuccinate synthetase (ASS)
and arginosuccinate lyase (ASL)
in the cerebral cortex of control
and TAA rats. Results are mean ±
SD; (n=4–5) *p<0.05 vs.
“Control”
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synthesis in vivo. Exact evaluation of the contribution of
Cit transport that could be a regulatory mechanism capa-
ble of modulating NO synthesis in the different CNS cell
types will require further investigation.
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